Androgen receptor level controlled by a suppressor complex lost in an androgen-independent prostate cancer cell line
Wang, Long G; Ossowski, Liliana; Ferrari, Anna C.
Oncogene
; 23: 5175-84, 2004. ilus
Artículo en Inglés | URUCAN | ID: bcc-3326
Documentos relacionados
How to Study Basement Membrane Stiffness as a Biophysical Trigger in Prostate Cancer and Other Age-related Pathologies or Metabolic Diseases
Cyclooxygenase 2 expression in colorectal cancer with DNA mismatch repair deficiency
Using a variant of coverslip hypoxia to visualize tumor cell alterations at increasing distances from an oxygen source
Tumor-associated Endo180 requires stromal-derived LOX to promote metastatic prostate cancer cell migration on human ECM surfaces
Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network
Room-Temperature Broadband Light Emission from Hybrid Lead Iodide Perovskite-Like Quantum Wells: Terahertz Spectroscopic Investigation of Metastable Defects
Survival Outcome and EMT Suppression Mediated by a Lectin Domain Interaction of Endo180 and CD147
An integrated view of the role of miR-130b/301b miRNA cluster in prostate cancer
Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk
Clinical significance of tumor expression of major histocompatibility complex class I-related chains A and B (MICA/B) in gastric cancer patients